Sofinnova Investments, Inc. - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 152 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.5%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$7,261,000
+72.7%
346,770
+97.3%
0.66%
+25.4%
Q4 2018$4,205,000
-30.7%
175,775
-20.9%
0.52%
-3.1%
Q3 2018$6,064,000
-45.5%
222,295
-46.2%
0.54%
-23.7%
Q2 2018$11,121,000
+1621.5%
413,572
+1936.5%
0.71%
+538.7%
Q1 2018$646,00020,3080.11%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders